Company profile for CytoDyn

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CytoDyn is committed to enhancing the lives of patients through target specific medicine. Our team is focused on developing Leronlimab, a monoclonal antibody CCR5 receptor antagonist, to be used as a platform drug for a variety of indications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1111 Main Street Suite 660 Vancouver, WA 98660
Telephone
Telephone
360-980-8524
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
December 2025 Letter to Shareholders
December 2025 Letter to Shareholders

16 Dec 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/12/16/3206218/19782/en/December-2025-Letter-to-Shareholders.html

GLOBENEWSWIRE
16 Dec 2025

https://www.globenewswire.com/news-release/2025/12/01/3196995/19782/en/CytoDyn-Announces-Resolution-of-Class-Action-Lawsuit.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/24/3193500/19782/en/CytoDyn-to-Present-Prolonged-Survival-Data-on-Leronlimab-in-Metastatic-Triple-Negative-Breast-Cancer-at-the-San-Antonio-Breast-Cancer-Symposium.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179282/19782/en/CytoDyn-Secures-30-Million-Commitment-from-Yorkville-Advisors.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/09/3164132/19782/en/CytoDyn-to-Present-at-the-LD-Micro-Main-Event-XIX-Investor-Conference.html

GLOBENEWSWIRE
09 Oct 2025
September 2025 Letter To Shareholders
September 2025 Letter To Shareholders

30 Sep 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/09/30/3158612/19782/en/September-2025-Letter-to-Shareholders.html

GLOBENEWSWIRE
30 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty